RecruitingNCT01246765
National Pregnancy Registry for Psychiatric Medications
Sponsor
Massachusetts General Hospital
Enrollment
5,000 participants
Start Date
Nov 1, 2008
Study Type
OBSERVATIONAL
Conditions
Summary
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical antipsychotics that many people take during pregnancy to treat a wide range of mood, anxiety, executive function, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years
Inclusion Criteria4
- Pregnant women
- Age 18-45
- Subjects will be willing to participate over the phone
- Subjects will be able to provide informed consent
Exclusion Criteria3
- Women who have completed their pregnancy
- Women who are planning to become pregnant
- Women who are not taking any psychiatric medications and/or have no history of psychiatric illness
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01246765
Related Trials
Outpatient Induction of Labour Using a Double Balloon Transcervical Catheter in Low-risk Pregnant Women: a Two-centre Open Prospective Randomised Controlled Trial - OutCRIB
NCT072655182 locations
Nebulized Ketamine for the Treatment of Major Depressive Disorder
NCT067527591 location
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
NCT054465711 location
Effect of Helfer Skin Tap and Cold Application on Pain and Hemodynamics During Vaccination
NCT069766321 location
Association Between Intake of Psychotropic Medications and Risk of Falls in Older Adults
NCT071125731 location